First human trial launches for Next-Generation mRNA HIV vaccines
NCT ID NCT07390474
Summary
This is a first-in-human, early-stage trial to test the safety and immune response of two new experimental HIV vaccines. The vaccines, called DV201P-RNA and DV202B1-RNA, use mRNA technology (similar to some COVID-19 vaccines) to train the immune system to fight HIV. The study will enroll 40 healthy adult volunteers who do not have HIV to receive the vaccines and be closely monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Columbia P&S CRS
New York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Penn Prevention CRS
Philadelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Hope Clinic of the Emory Vaccine Research Center; Emory University
Decatur, Georgia, 30030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Ponce de Leon Center CRS
Atlanta, Georgia, 30308, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Rochester Vaccines to Prevent HIV Infection CRS
Rochester, New York, 14642, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.